SecBot SecBot
25-NSE ·Filed Oct 30, 2026

BFRI

Biofrontera Inc.
NEUTRAL
Impact 4/10
Horizonimmediate Processed2d 1h ago SEC0001354457-26-001041
Notable filing: 25-NSE
Actionable Insight • Neutral

The warrant delisting eliminates a potential dilutive overhang if the warrants were exercised. Monitor for any subsequent filing by Biofrontera regarding the warrant redemption or maturity terms. The common stock listing remains intact.

DirectionNeutral
Confidencehigh
Horizonimmediate

Price Chart

Loading chart...

Executive Summary

Nasdaq filed a Form 25-NSE to delist Biofrontera Inc.'s warrants (ticker BFRIW) under SEC Rule 12d2-2(a)(2), which applies to matured, redeemed, or retired securities. The filing became effective immediately on October 30, 2026. The company's common stock (BFRI) is not affected by this delisting action.

Key Facts

  • Form 25-NSE filed by Nasdaq Stock Market LLC to remove Biofrontera Inc.'s warrants from listing and registration
  • Delisting based on 17 CFR 240.12d2-2(a)(2), matured, redeemed, or retired securities
  • Effectiveness date is October 30, 2026
  • Only the warrants (ticker BFRIW) are being delisted; common stock (BFRI) is not mentioned in the delisting

Financial Impact

Warrant delisting removes a publicly traded security; no cash impact on the company. Biofrontera's market cap is $13M.

dilutioncapital structure

Risk Factors

  • Warrant holders may lose liquidity if the warrants are not exercised before delisting
  • No information provided on whether the warrants were redeemed or expired; terms of the warrant agreement are not in the filing

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (8 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
25-NSE Filing (Primary)0001354457-26-001041
Document: 0001354457-26-001041-index-headers.html0001354457-26-001041
Document: 0001354457-26-001041-index.html0001354457-26-001041
Document: 0001354457-26-001041.txt0001354457-26-001041
7 reports for BFRI
Performance horizon
67% Hit rate @ T+60 2 of 3 directional calls Went positive at some point 3 of 5 best @ T+20▲ +28.50%Mar 19, 2026
Filters
Rows
Reports for BFRI, sortable and filterable
TypeNow
Oct 30, 2026
2d ago
25-NSE
NEUTRAL ★ 4/10
$0.9400awaiting T+60awaiting T+60$0.8730 (−7.13%)
Sep 14, 2026
6w ago
8-K
BULLISH ★ 7/10
$1.36awaiting T+60awaiting T+60$0.8730 (−35.81%)
Aug 13, 2026
11w ago
8-K
BULLISH ★ 7/10
$1.26awaiting T+60awaiting T+60$0.8730 (−30.71%)
May 14, 2026
24w ago
Press Release
BULLISH ★ 7/10
$0.9890 $1.21▲ +22.35%▲ +18.76%$0.8730 (−11.73%)
May 8, 2026
25w ago
Press Release
NEUTRAL ★ 1/10
$1.11 $1.24▲ +11.71%▲ +7.32%$0.8730 (−21.35%)
Mar 19, 2026
32w ago
Press Release
BULLISH ★ 8/10
$0.8560 $1.00▲ +16.82%▲ +2.48%$0.8730 (+1.99%)
Feb 26, 2026
35w ago
8-K
BULLISH ★ 8/10
$0.9270 $0.7790▼ −15.97%▼ −23.72%$0.8730 (−5.83%)
Showing 7 of 7

US Market Status

Market Closed · Opens Mon (17h 21m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 30, 2026